RETA withdrawal reversed metabolic benefits, but tumor suppression remained persistent Patients often do not tolerate the side effects of medical weight loss, including nausea or gut discomfort 31 , or may not have access to the prescriptions due to financial burdens or lack of availability
What sets Ipamorelin apart is its selectivity, as it does not appear to influence the release of other hormones from the pituitary gland, such as prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), or Adrenocorticotropic hormone (ACTH)
J Appl Physiol
Mller TD, Finan B, Bloom S, DAlessio D, Drucker DJ, Flatt P, Fritsche A, Gribble F, Grill H, Habener J
This reduced variability may provide benefits beyond what average glucose levels indicate, since glucose fluctuations themselves appear to contribute to metabolic dysfunction and vascular damage